In today’s Pharma Pulse, Cold Chain Technologies sets a formal 2050 Net Zero goal to tackle the industry’s Scope 3 emissions, ...
CCT’s 2050 Net Zero goal will tackle Scope 3 emissions, which make up the majority of Pharma’s carbon footprint. Cold Chain ...
Amber Hussain-Siddique says operational discipline in inventory and logistics is the vital, yet overlooked, key to sustaining ...
In today’s Pharma Pulse, Eli Lilly calls for the U.K. government to overhaul its drug pricing framework and the FDA approves ...
Chris Dowd and Lisa Prowker of ConnectiveRx discuss point-of-care marketing as the key activation layer for investments in ...
Armstrong emphasizes that speed is a fundamental measure of success, and beyond timeliness, he notes that DTP programs offer ...
The role of hub services is undergoing a fundamental shift. No longer confined to administrative tasks like benefits verification and prior authorizations, today’s hybrid hub models are evolving into ...
In today's Pharma Pulse, the FDA flags misleading promotional claims from ImmunityBio regarding its cancer therapy and ...
In today’s Pharma Pulse, experts warn of zero-prefix collision risks in the NDC-12 transition, and the FDA grants accelerated ...
Jordan Armstrong outlines how adaptable DTP programs can reduce barriers and accelerate patient access to therapy. As ...
In the final installment of Pharmaceutical Commerce’s interview with Nareda Mills, global president of Patient Solutions at ...
As global temperatures continue to rise and weather patterns grow more volatile, the pharmaceutical industry faces a mounting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results